Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 13, 2026)


SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
83 GF Score
Price ¥8.09
GF Value ¥10.22
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Zhejiang Ausun Pharmaceutical Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:603229 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Ausun Pharmaceutical Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:603229
83GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.09 is trading 20.8% below its estimated GF Value™ of ¥10.22. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥10.22 vs. price of ¥8.09 (20.8% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
83GF Score

Get the complete analysis for SHSE:603229

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.09
Price
¥10.22
GF Value